Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search
  1. Home
  2. News & events
Filter by
  • Filter by
  • Remove this filter Infectious disease: Influenza in humans, pandemic
  • Remove this filter Public health area: Immunisation
  • Remove this filter Public health area: Vaccination
  • Remove this filter Public health area: Active immunisation
  • Infectious disease
    • Influenza in humans, pandemic (9)
    • Vaccine preventable diseases (9)
    • Respiratory diseases (9)
    • Influenza (9)
    • Influenza in humans, seasonal (6)
    • Seasonal influenza (6)
    • Flu (6)
    • Influenza A (H1N1)2009 (5)
    • Influenza A (H1N1) (5)
    • Mosquito-borne diseases (1)
    • Guillain-Barré syndrome (1)
  • Public health area
    • Immunisation (9)
    • Vaccination (9)
    • Active immunisation (9)
    • Vaccine safety (5)
    • Pandemic preparedness (2)
    • Prevention and control (1)
    • Surveillance (1)
    • Vaccination coverage (1)
    • Vaccine efficacy (1)
    • Disease prevention (1)
    • Prophylaxis (1)
    • Vaccine effectiveness (1)
    • Vaccine hesitancy (1)
  • Country
    • Europe (5)
  • Media type
    • News (7)
    • ECDC comment (6)
    • Event (2)
    • Press release (1)
  • All (9)
  • News (7)
  • Event (2)
  • Page 1 of 1 // 9 Results found
    • Sort by:

News

WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season

ECDC comment - 3 Oct 2017

The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.

  • Immunisation
  • Influenza A (H1N1)2009
  • Influenza in humans, pandemic
  • Influenza in humans, seasonal
  • Surveillance

News

Low uptake of seasonal influenza vaccination in Europe may jeopardise capacity to protect people in next pandemic

Press release - 7 Feb 2018

Influenza vaccination coverage among high-risk groups has dropped in the European Region over the last seven years, and half the countries report a decrease in the number of vaccine doses available.

  • Europe
  • Immunisation
  • Influenza
  • Influenza in humans, pandemic
  • Influenza in humans, seasonal
  • Vaccination coverage
  • Vaccine effectiveness
  • Vaccine efficacy
  • Vaccine hesitancy
Oct 2011

Event

The use of vaccines for prevention of seasonal and pandemic influenzaArchived

Event
3 Oct 2011
ECDC
ECDC

On 3 October 2011 European Centre for Disease Prevention and Control (ECDC) and representatives of the European Vaccine Manufacturers  met at ECDC in Stockholm for a regular scheduled meeting about the use of vaccines for prevention of seasonal and pandemic influenza. ECDC Director Marc Sprenger opened the meeting and ECDC influenza experts held different presentations, such as burden of influenza disease in the EU, risk groups for severe influenza disease, personal protective measures, pandemic influenza preparedness, seasonal influenza vaccines, communication.
The Declarations of Interest for ECDC Influenza Staff and the ECDC Director are available here under ECDC Transparency.

  • Director
  • Immunisation
  • Influenza
  • Influenza in humans, pandemic
  • Prevention and control
Oct 2015

Event

Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines

Event
23 Oct 2015
Geneva, Switzerland
International Alliance for Biological Standardisation and the World Health Organization

​This meeting was designed to offer a place to exchange the latest information on into the development of narcolepsy following vaccination with one of the 2009 adjuvanted influenza A(H1N1) vaccines.

  • EU/EEA
  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, pandemic
  • Influenza in humans, seasonal
  • Vaccine safety

News

No association found between pandemic influenza vaccination and Guillain-Barre Syndrome in EuropeArchived

ECDC comment - 13 Jul 2011

Due to an association that was observed in the United States between a swine-flu based human influenza vaccine developed in 1976 and the disease acute polyneuropathy Guillain-Barré syndrome (GBS) (1,2), GBS was one of the adverse events that was monitored in Europe and North  America (3) following the 2009 influenza pandemic vaccination campaigns.

  • Europe
  • Guillain-Barré syndrome
  • Immunisation
  • Influenza in humans, pandemic
  • Pandemic preparedness
  • Vaccine preventable diseases
  • Vaccine safety

News

Report on the association between the 2009 pandemic vaccine (Pandemrix®) and narcolepsy – Republic of IrelandArchived

ECDC comment - 19 Apr 2012

Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010 - Final Report of National Narcolepsy Study Steering Committee, Department of Health, Ireland

  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, pandemic
  • Influenza in humans, seasonal
  • Ireland
  • Vaccine safety

News

WHO announcement of strains to be included in the Southern Hemisphere 2013 influenza vaccine compositionArchived

ECDC comment - 11 Oct 2012

Following a meeting of the global influenza collaborating centres in Beijing hosted by the newest Centre that in China the World Health Organization (WHO) recently recommended that influenza vaccines to be used in the 2013 Southern Hemisphere (SH) influenza season should contain the same three strains as the vaccines that now are being used in the Northern Hemisphere (NH).

  • Immunisation
  • Influenza
  • Influenza in humans, pandemic
  • Pandemic preparedness

News

No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix™ Vaccination Campaign in Finland

ECDC comment - 15 Aug 2013

This is the first published study where an attempt has been made to understand the possible biological mechanisms behind development of narcolepsy following vaccination with Pandemrix™.

  • Finland
  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, pandemic
  • Influenza in humans, seasonal
  • Vaccine safety

News

Update on narcolepsy cases associated with Pandemrix vaccination in 2009 in the Netherlands

ECDC comment - 22 Dec 2014

​In November 2014, the Pharmacovigilance Centre of Netherlands (Lareb) provided an updated overview of Dutch cases of narcolepsy reported to have a link to Pandemrix.

  • Immunisation
  • Influenza A (H1N1)2009
  • Influenza in humans, pandemic
  • Influenza in humans, seasonal
  • Vaccine safety
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2021
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us